Idelfonso Méndez

No bio yet

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Infinity Pharmaceuticals

Infinity Pharmaceuticals, Inc., is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.